NCT05301881View on ClinicalTrials.gov

COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study

PHASE2RecruitingINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

April 17, 2023

Primary Completion Date

April 1, 2035

Study Completion Date

April 1, 2040

Conditions
Breast Cancer InvasiveMetastatic CancerOligoprogressive
Interventions
PROCEDURE

Surgery

resection of the oligometastatic lesion(s)

RADIATION

Radiotherapy

radiation of the oligometastatic lesion(s)

OTHER

Radiofrequent ablation

radiofrequent ablation of the oligometastatic lesion(s)

Trial Locations (7)

Unknown

NOT_YET_RECRUITING

Noordwest Ziekenhuisgroep, Alkmaar

RECRUITING

Antoni van Leeuwenhoek, Amsterdam

RECRUITING

Rijnstate, Arnhem

NOT_YET_RECRUITING

Deventer ziekenhuis, Deventer

RECRUITING

ADRZ, Goes

NOT_YET_RECRUITING

Martini ziekenhuis, Groningen

NOT_YET_RECRUITING

Antonius ziekenhuis, Utrecht

All Listed Sponsors
collaborator

Maarten van de Weijden Foundation

UNKNOWN

lead

The Netherlands Cancer Institute

OTHER